-
to apply for a faculty or staff position, please review this tip sheet . The Molecular and Cellular Pharmacology Department is seeking a Senior Bioinformatics Analyst to work full-time, on-site in Miami, FL
-
Bioinformatics analysis of associated data Perform basic analyses of next-generation sequencing data including quality control filtering and bioinformatics interpretation Conduct research in human disease models
-
and other faculty members within the Biostatistics and Bioinformatics Shared Resources (BBSR) of SCCC to provide comprehensive support in data management, methodological development, advanced
-
trusted voice in digital health, technology and transformation. The Research Assistant Professor will serve as the MIL site expert in bioinformatics setting the strategic vision for the group, leading
-
, bioinformatics, and pharmacology. The Miller School is home to the renowned John P. Hussman Institute for Human Genomics and is a leader in federal research funding and clinical trials, including the PRIME Study
-
, bioinformatics, and pharmacology. The Miller School is home to the renowned John P. Hussman Institute for Human Genomics and is a leader in federal research funding and clinical trials, including the PRIME Study
-
, developmental biology, stem cell biology, or imaging and bioinformatics. The department is home for the administration of the graduate program in Molecular Cell and Developmental Biology, an interdepartmental
-
are searching for a candidate with expertise in environmental DNA (eDNA) laboratory practices as well as bioinformatics to contribute to our ongoing work with eDNA. Duties will include eDNA field collection
-
across physiology, genetics, neuroscience, bioinformatics, and pharmacology. The Miller School is home to the renowned John P. Hussman Institute for Human Genomics and is a leader in federal research
-
), bioinformatics and value-based models of cancer survivorship care; health disparities in specific survivorship subgroups (e.g., LGBT; Hispanics; Elderly); cardiometabolic health in cancer survivors; and/or